pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,682 catalysts · 6,366 phase readout · 2,310 8k filing · 389 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 19 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,366
  • 8k filing2,310
  • earnings389
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT03819101: Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: PHASE3. Conditions: Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07609875: A Phase I Single and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HS-10522 in Healthy Chinese Participants and Chinese Participants With Mild Hypertension

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult, Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07329075: Soft Robot for Rehabilitation of Hand Function After Stroke

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›WITHHELDphase readoutNCT06042101: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT07402512: A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children

Sponsor: Simcere Pharmaceutical Co., Ltd. Phase: PHASE3. Conditions: Respiratory Syncytial Virus Infection

full page →ctgov ↗
›WITHDRAWNphase readoutNCT07375212: VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure

Sponsor: Prisma Health-Upstate. Phase: PHASE4. Conditions: Heart Failure Congestive

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06477003: Multispectral Optoacoustic Tomography in Head and Neck Squamous Cell Cancer

Sponsor: University of Oklahoma. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05862688: A Cohort Study on Anti-microbial Stewardship in PICU

Sponsor: Children's Hospital of Fudan University. Phase: . Conditions: Infections

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07458542: Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia

Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Acute Myeloid Leukemia (AML)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06906042: Multimodal Cardiovascular and Hepatic Population Imaging

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Healthy Volunteers, Imaging Evaluation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00679042: Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

Sponsor: CellTrans Inc.. Phase: PHASE3. Conditions: Type 1 Diabetes Mellitus

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07596342: Electrophysiological Analysis of Gamma-Hydroxybutyrate-induced Sleep in Intensive Care Patients

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Sleep Disorder (Disorder), Critical Care

full page →ctgov ↗
›COMPLETEDphase readoutNCT04469686: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Sponsor: Cristcot HCA LLC. Phase: PHASE3. Conditions: Ulcerative Proctitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06387186: Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy

Sponsor: Elizabeth Anne Thiele. Phase: PHASE1. Conditions: Refractory Epilepsy, Drug Resistant Epilepsy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07489573: Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Sponsor: Novartis Pharmaceuticals. Phase: PHASE4. Conditions: Hidradenitis Suppurativa (HS)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05524883: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Sponsor: Dyne Therapeutics. Phase: PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07615569: Robot-assisted Versus Conventional Physical Therapy for Hand in Sub-acute Stroke

Sponsor: Montiha Azeem. Phase: NA. Conditions: Stroke, Spastic Hemiplegia, Upper Limb Motor Impairment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07416669: Death, Dying, Violence and Aggression as Shown on Medical Television Series.

Sponsor: King's College Hospital NHS Trust. Phase: . Conditions: End of Life Care, Violent Aggressive Behavior, Television Viewing, Media Use

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04430569: Pulmonary Embolism International THrOmbolysis Study-3

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Pulmonary Embolism

full page →ctgov ↗
›RECRUITINGphase readoutNCT05354869: Transvaginal Electrical Stimulation for Myofascial Pelvic Pain

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Myofascial Pelvic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06544083: Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: . Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT02560883: Hairy Cell Leukemia Patient Data Registry

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: . Conditions: Leukemia, Other

full page →ctgov ↗
›COMPLETEDphase readoutNCT07186283: Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers

Sponsor: NW PharmaTech Ltd. Phase: PHASE1. Conditions: PK in Healthy Volunteers

full page →ctgov ↗
›TERMINATEDphase readoutNCT03939169: The Efficiency of Using Supportive Postures and Holding Techniques to Minimize Premature Infant Pain (PAP)

Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: NA. Conditions: Premature Infant

full page →ctgov ↗
›WITHHELDphase readoutNCT06210841: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›COMPLETEDphase readoutNCT00944541: Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis. Phase: PHASE2. Conditions: HIV Infection, HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT07001241: Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Cancer-related Fatigue, Breast Cancer, Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07492173: Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Sponsor: Shandong New Time Pharmaceutical Co., LTD. Phase: NA. Conditions: Solid Tumor Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06981169: PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults

Sponsor: Université de Sherbrooke. Phase: . Conditions: Asthma, Inflammation, Asthma in Children

full page →ctgov ↗
›COMPLETEDphase readoutNCT07645183: Advanced Technology for Myopia Control in Children and Young Adults

Sponsor: University of Faisalabad. Phase: NA. Conditions: Myopia (Disorder), Refraction Error

full page →ctgov ↗
›RECRUITINGphase readoutNCT05895383: Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy

Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Procedural Pain, Pain Catastrophizing, Procedural Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT07217769: Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Shift Work

full page →ctgov ↗
›RECRUITINGphase readoutNCT06571669: BOOM-IBD2 Pivotal Clinical Trial

Sponsor: Boomerang Medical. Phase: NA. Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07492641: BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

Sponsor: BeOne Medicines. Phase: PHASE3. Conditions: HR+/HER2- Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05608083: HEARTS R34 Feasibility Study, Autistic Participants

Sponsor: Boston University Charles River Campus. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03619083: Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07749469: Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin

Sponsor: USMARI Research & Innovation Centre. Phase: NA. Conditions: Acne

full page →ctgov ↗
›RECRUITINGphase readoutNCT06651983: Association of Inflammatory Factors With Complications in the Diabetic Population: a Cross-sectional Study

Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05797441: Testing the Effectiveness of a Therapist-Assisted Self-Management Program for Veterans Who Finished PTSD Therapy

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD, Post Traumatic Stress Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT05713669: Impact of Resident Participation in Post-ICU Follow Up Clinic

Sponsor: University of Michigan. Phase: NA. Conditions: Professional Burnout

full page →ctgov ↗
›RECRUITINGphase readoutNCT07597083: Biofeedback-Assisted Pelvic Floor Rehabilitation for Radiation-Induced Sexual Dysfunction in Cervical Cancer Survivors

Sponsor: Beni-Suef University. Phase: NA. Conditions: Cervical Cancer, Female Sexual Dysfunction (FSD), Radiation Induced Pelvic Floor Muscle Dysfunction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07376083: Ultrasound vs Chest X-ray for NG Tube Placement in ICU

Sponsor: Tepecik Training and Research Hospital. Phase: . Conditions: Intensive Care (ICU)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07660341: SAD Study of CGB3002 in Healthy Participants

Sponsor: ChainGen Biopharma Ltd. Phase: PHASE1. Conditions: Alzheimer s Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05690841: FocaL Mass Drug Administration for Vivax Malaria Elimination

Sponsor: University of California, San Francisco. Phase: PHASE3. Conditions: Plasmodium Vivax Malaria, Malaria

full page →ctgov ↗
›RECRUITINGphase readoutNCT05822141: Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure

Sponsor: Indiana University. Phase: NA. Conditions: Cold Exposure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07296341: HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors

Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Locally Advanced or Metastatic Pancreatic Cancer With

full page →ctgov ↗
›COMPLETEDphase readoutNCT07204483: Feasibility Trial of Functional Clothing, Moderate Exercise, and Health Information for Stress Reduction and Behavior Change in Okinawa

Sponsor: Shinyu Kise. Phase: NA. Conditions: Obesity, Metabolic Syndrome, Stress, Psychological

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07707583: Heart Rate Variability and Medication Adherence in Resistant Hypertension

Sponsor: Nemocnice AGEL Trinec-Podlesi a.s.. Phase: . Conditions: Resistant Hypertension, Medication Adherence, Autonomic Nervous System

full page →ctgov ↗
›COMPLETEDphase readoutNCT03652441: Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

Sponsor: University of Cologne. Phase: PHASE2. Conditions: Classical Hodgkin Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05296954: Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping.

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Atrioventricular Nodal Reentry Tachycardia, Supraventricular Tachycardia

full page →ctgov ↗
← prev
page 167 of 174
next →